NASDAQ$NUTX

Nutex Health Inc · Q1 2022 earnings

Q1 2022 earnings ·

Headline financials

Total Revenue

$6.21M

Previous: $2.01M+208.2%
Capital Expenditures

-$1.42K

No prior period
Free Cash Flow

-$16.6M

Previous: -$4.44M-272.8%
Net Income

-$16.6M

Previous: -$4.44M-272.8%
Operating Income

-$16.4M

Previous: -$4.15M-294.4%
Gross Profit

$1.72M

Previous: $427K+302.1%
Cash & Equivalents

$12.7M

Previous: $3.74M+239.9%
Total Assets

$83.3M

Previous: $75.9M+9.7%

Revenue & EPS history

Nutex Health Inc · Revenue · Quarterly

$6.21M

Q1 2022+208.2%vs Q1 2021
Beat estimate in 2 of 2 quarters(100%)
ActualEstimate

Revenue by segment

Nutex Health Inc · $244M total across 2 segments · Q2 2025

  • Hospital Division
    $236M—
  • Population Health Management
    $7.68M—

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 12 quarterly earnings reports

Historical avg

+1.9%

Avg return

Earnings day

+17.2%

Avg return

5 days after

+21.1%

Avg return

30 days after

62%

8 / 13 earnings

Positive

+22.4%

Q1 2022

Best reaction

-14.3%

Q4 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q2 2025———
Q1 2026+6.4%+8.0%+14.4%
Q4 2025-14.3%-14.1%-4.2%
Q3 2025+0.0%+32.9%+64.1%
Q1 2025+1.0%+40.2%+0.2%
Q3 2024+6.3%+38.2%+39.3%
Q2 2024+0.9%+62.7%+173.1%
Q1 2024+6.2%+14.8%+0.7%
Q3 2023+0.0%-6.0%-22.8%
Q2 2023+3.6%+0.9%-20.1%
Q1 2023+8.9%+10.3%-17.8%
Q3 2022-9.2%+1.7%+59.7%
Q2 2022-8.2%-27.9%-53.8%
Q1 2022+22.4%+61.8%+41.2%
Q3 2021———
Q2 2021———
Q1 2021———
Q3 2020———
Q1 2020———
Q3 2019———
Q1 2019———
Q2 2018———
Q2 2016———
Q3 2014———
Q1 2014———
Q3 2013———
Q2 2013———

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro